BIO-key International (NASDAQ:BKYI) Stock Passes Above Fifty Day Moving Average – Time to Sell?

BIO-key International Inc. (NASDAQ:BKYI)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.61 and traded as high as $0.70. BIO-key International shares last traded at $0.6455, with a volume of 1,965,663 shares changing hands.

Wall Street Analysts Forecast Growth

BKYI has been the subject of several research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Wednesday, January 21st. Wall Street Zen raised BIO-key International to a “sell” rating in a report on Saturday, January 3rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, BIO-key International currently has an average rating of “Sell”.

BIO-key International Trading Down 2.4%

The business’s 50 day simple moving average is $0.61 and its 200 day simple moving average is $0.68. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.26 and a quick ratio of 1.13. The company has a market capitalization of $6.84 million, a price-to-earnings ratio of -0.90 and a beta of 0.50.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings data on Tuesday, March 31st. The technology company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.12). The company had revenue of $1.24 million for the quarter, compared to analysts’ expectations of $2.20 million. BIO-key International had a negative net margin of 75.32% and a negative return on equity of 67.43%.

Institutional Trading of BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC raised its stake in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors own 26.51% of the company’s stock.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.